BUTALBITAL

Generic: BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

QUAGEN PHARMACEUTICALS LLCManufacturer
ORALRoute
BUTALBITALActive Substance
2024-02-08Original Approval

BUTALBITAL is FDA application ANDA214288, sponsored by QUAGEN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
HEADACHE
269 reports
2
DRUG INEFFECTIVE
224 reports
3
NAUSEA
214 reports
4
FATIGUE
207 reports
5
PAIN
193 reports
6
COMPLETED SUICIDE
185 reports
7
DIARRHOEA
156 reports
8
MIGRAINE
146 reports
9
TOXICITY TO VARIOUS AGENTS
145 reports
10
DYSPNOEA
134 reports